Dianthus therapeutics highlights recent business achievements and reports q3 financial results

Initiation of a single, two-part, pivotal phase 3 trial of dnth103 in chronic inflammatory demyelinating polyneuropathy (cidp) anticipated by ye'24

DNTH Ratings Summary

DNTH Quant Ranking